NCT02426099View on ClinicalTrials.gov

Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Hypertension, Resistant to Conventional TherapyDiabetes Mellitus
Interventions
DRUG

Low dose spironolactone

4-week add-on low dose spironolactone in resistant hypertension

OTHER

Routine intensification of antihypertensive treatment

4-week guidelines oriented intensification of antihypertensive treatment

Trial Locations (1)

Unknown

National Obesity Centre, Yaounde Central Hospital, Yaoundé

All Listed Sponsors
collaborator

University of Yaounde 1

OTHER

lead

Sobngwi Eugene

OTHER_GOV

NCT02426099 - Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension | Biotech Hunter | Biotech Hunter